ClinicalTrials.gg
Drug

Leuprolide clinical trials

Also written Lupron, Leuprorelin, Lupron Depot and CKD-841.

Includes 9 studies of Luprolide acetate gel depot and 3 studies of Leuprolide mesylate.

studies test it
153
open now
17
in phase 3
44
first study started
1991

How each study uses Leuprolide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Leuprolide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 Apr 1985 · LUPRON · NDA 019010 (FDA, Drugs@FDA)
European Union
24 May 2022 · Camcevi · EMEA/H/C/005034 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Leuprolide Acetate
47
Leuprolide
28
Leuprolide Acetate 3.75 MG/ML
2
Lupron Deport
2
Goserelin
2

Brand

Lupron
32
Lupron Depot
8
Enantone
6
Eligard
5
lucrin
3
Leuplin
2
ELIGARD 22.5 mg
1
Trenantone
1

Development codes

CKD-841
2
ABT-818
2
A-43818
1
TAP-144SR
1
PT105
1
DWJ108J
1

Other names

Leuprorelin
18
Leuprorelin acetate
10

Studies by the year they started

151 studies that test it; most in 2014 (9)

Studies that test Leuprolide, by start year
YearStudies
19911
19922
19931
19942
19962
19972
19992
20001
20011
20021
20038
20043
20054
20065
20077
20085
20098
20103
20116
20124
20136
20149
20157
20164
20177
20187
20193
20208
20216
20224
20239
20246
20252
20265

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
13
Phase 2
54
Phase 3
44
Phase 4
26
No phase
19

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 45 · Other 108

Takeda (6) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (5) · Abbott (5) · National Cancer Institute (NCI) (3) · University of Colorado, Denver (3) · University of North Carolina, Chapel Hill (3) · GP-Pharm (3) · University of Chicago (3)

Often tested with

Tested in the same studies.

Goserelin (16) · Bicalutamide (14) · Degarelix (9) · Flutamide (8) · Triptorelin (8) · Estradiol (7) · Abiraterone (6) · Darolutamide (5)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Leuprolide is the comparator. A study of two new drugs counts under both.

  • 1Linzagolix · Kissei Pharmaceutical Co., Ltd. · next primary completion Nov 2027
Reaching primary completion within a year · 12, 4 in phase 3

Studies that test Leuprolide, phase 3 first.

Studies

Open first, then newest update. How each study uses Leuprolide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 153

See all 153 studies that test Leuprolide →

Given beside what is tested · 87 — Leuprolide is usual care or a partner of the new treatment

Showing 20 of 87.

As the comparator · 39 — what is tested is compared with Leuprolide

Showing 20 of 39.

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Leuprolide · ClinicalTrials.gg INT008545

  • MeSH (NLM) D016729LeuprolideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) EFY6W0M8TGLEUPROLIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 42375Confirmed FDA, Wikidata
  • Wikidata Q907160leuprolideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62042LeuprolideOne source FDA
  • DrugBank DB00007One source Wikidata

Also registered as leuprolide acetate (UNII 37JNS02E7V · RxNorm 203217).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.